Gene therapy for keratin genodermatoses: striving forward but obstacles persist

Area of Science:

• Cell Biology
• Genetics
• Dermatology

Background:

• Investigated stress responses in keratinocyte cell lines with a keratin 14 (K14)-null mutation.
• Assessed phenotypic rescue by wild-type K14 in a K14-null background.
• Utilized a K14-null mutation model to study keratin genodermatoses.

Discussion:

• Demonstrated that transfecting wild-type K14 into K14-null cells can normalize cellular function and reduce stress responses.
• Highlighted that dominant negative mutations, common in patients, are more disruptive than null mutations.
• Identified persistent hurdles for in vivo gene therapy, including gene delivery and stable mutation correction in skin.

Key Insights:

• Wild-type K14 can rescue the K14-null phenotype in vitro.
• Gene therapy holds promise for keratin genodermatoses.
• In vivo application faces significant challenges due to mutation type and delivery methods.

Outlook:

• Further research needed to overcome in vivo gene delivery obstacles.
• Developing strategies for targeting dominant negative mutations is crucial for clinical translation.
• Advancing gene therapy for inherited skin blistering diseases requires addressing delivery and stability issues.